jcp conference-coverage

Conference Coverage

News

Cancer Care at Home: Opportunities, Risks, and How to Prepare

10/11/2023

Aaron Gerber, Raj Hazarika, Barbara McAneny, Barry Russo, Harlan Levine, and Lindsey Zinck explore the potential of cancer care at home and the challenges it may bring.

Aaron Gerber, Raj Hazarika,...

10/11/2023

Journal of Clinical Pathways

The Scaling Precision Medicine panel at CPC & CBEx 2023.

News

Scaling Precision Medicine Expertise for Equitable Cancer Care: Breaking Barriers, Advancing Patient Outcomes

10/10/2023

Brandon Twyford ;

Ivy Altomare, MD, Debyani Chakravarty, PhD, James Hamrick, MD, and John W. Sweetenham, MD, discussed the ways precision medicine can help advance equity in health care at CPC & CBEx 2023 in Boston.

Ivy Altomare, MD, Debyani...

10/10/2023

Journal of Clinical Pathways

Frederick Schnell, MD, Nicolas Ferreyros, and Barbara McAneny, MD, discuss health care advocacy and policy at CPC & CBEx 2023

News

How Congress Plans to Address Patient and Hospital Challenges, and How This Could Affect Oncologists

10/10/2023

Emry Lloyd ;

At CPC & CBEx 2023, Barbara McAneny, MD, Nicolas Ferreyros, and Frederick Schnell, MD, shared insight into Congress’s plan to address specific patient and hospital concerns, and how it might affect oncologists.

At CPC & CBEx 2023, Barbara...

10/10/2023

Journal of Clinical Pathways

Conference Coverage

The Future of AI in Cancer Care

10/08/2023

Will Shapiro ;

Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.

Will Shapiro, vice president of...

10/08/2023

Journal of Clinical Pathways

Conference Coverage

The Impact of Health Care Industry Consolidation on Cancer Care and Partnerships

10/08/2023

Emry Lloyd ;

Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.

Ronald Barkley, Barbara McAneny,...

10/08/2023

Journal of Clinical Pathways

News

CPC & CBEx Keynote Session: How Do We Define Value-Based Oncology Care?

10/07/2023

Brandon Twyford ;

The keynote session from the 2023 CPC & CBEx Annual Conference featured Harlan Levine, MD, City of Hope, in a thought-provoking presentation on what "value" in value-based care really means, and how to achieve a truly patient-centered model...

The keynote session from the...

10/07/2023

Journal of Clinical Pathways

Conference Coverage

Using Clinical Pathways to Reduce Delays in Time to Treatment

10/07/2023

Grace Taylor , MS, MA;

At CPC & CBEx 2023, Dennis R. Holmes, MD, discusses the impacts of delays in time to treatment for patients and how physician can use clinical pathways to provide more efficient treatment.

At CPC & CBEx 2023, Dennis R....

10/07/2023

Journal of Clinical Pathways

News

How Clinical Pathways Can be Used For HER2-Positive Breast Cancer Therapies

10/07/2023

Emry Lloyd ;

At CPC & CBEx 2023, Sayeh Lavasani, MD, discussed the different ways clinical pathways can be followed for HER2-positive breast cancer therapies.

At CPC & CBEx 2023, Sayeh...

10/07/2023

Journal of Clinical Pathways

News

CPC & CBEx 2023: Critical Trends in the Oncology Landscape

10/06/2023

Brandon Twyford ;

To open Friday’s schedule of sessions at the Clinical Pathways Congress & Cancer Care Business Exchange, Lee Blansett, MBA, Executive Vice President for HMP Market Access Insights, discussed critical trends in today’s oncology...

To open Friday’s schedule of...

10/06/2023

Cancer Care Business Exchange

Conference Coverage

AI in Cancer Care: Separating Fact from Fiction

10/06/2023

James Hamrick , MD, MPH;

James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.

James Hamrick, MD, discusses his...

10/06/2023

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

2024 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Update: Impact on NSCLC Landscape

11/15/2024

The updated 2024 NCCN Guidelines® recommend broad genomic testing and the need for multidisciplinary care to accurately diagnose and treat non-small cell lung cancer. View this special report to learn more.

The updated 2024 NCCN...

11/15/2024

Journal of Clinical Pathways

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Conference Coverage

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products